Dr. Lalos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Patterson Ave
Suite 5100B
New Brunswick, NJ 08901Phone+1 732-235-7784
Summary
- Hepatologist
Rutgers/Robert Wood Johnson Medical School
Assistant Professor of Medicine
Education & Training
- University of MIamiMD, Hepatology , 1990 - 1991
- University of ConnecticutFellowship, Gastroenterology, 1989 - 1990
- University of Virginia Medical CenterResidency, Internal Medicine, 1985 - 1988
- Perelman School of Medicine at the University of PennsylvaniaClass of 1985
- Harvard UniversityBA, Biochemistry, 1977 - 1981
Certifications & Licensure
- FL State Medical License 2014 - 2026
- NJ State Medical License 2021 - 2025
- MD State Medical License 2015 - 2024
- PA State Medical License 1991 - 2024
- DC State Medical License 2015 - 2022
- VA State Medical License 2015 - 2022
- CT State Medical License 1988 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 1 citationsRole of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.Aseel Y Abualnil, Ritesh Kumar, Mridula A George, Alexander Lalos, Mihir M Shah
Surgical Oncology Clinics of North America. 2024-01-01 - Inflammatory pseudotumors in the liver associated with influenza: A case report.Ankoor Patel, Alexander Chen, Alexander T Lalos
World Journal of Hepatology. 2023-10-27 - 2 citationsAlcohol-associated liver disease predicts increased post-liver transplant opioid use.Krystina A Johnson-Laghi, Stephanie M Woo, Zaeema Zafar, Stephen Fernandez, Sameer Desale
Clinical Transplantation. 2022-12-01
Journal Articles
- Ledipasvir/sofosbuvir is effective and well tolerated in post-kidney transplant patients with chronic hepatitis C virusMorales, AL, Liriano-Ward L, Tierney A, Sang M, Lalos, A, Hassan M, Nair, V., Schiano T, Satoskar R. and Smith, C., Clin Transplant, 1/1/2017
- Contrasting the Academic and Non-academic hepatology practice settingsLalos AT and Smith C, Clinical Liver Disease, 1/1/2017
- Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitisGeorgetson MJ, Yarze JC, Lalos AT, et al., American Journal of Gastroenterology, 1/1/1993
Books/Book Chapters
Abstracts/Posters
- Ledipasvir/sofosbuvir is effective and well tolerated in post-kidney transplant patients with chronic hepatitis C virus.Morales A, Liriano-Ward L, Lalos AT et al., AASLD Annual Meeting, 1/1/2016
- Red Cell Distribution Width to Platelet Ratio at the Time of Enrollment in United Network for Organ Sharing (UNOS) Waitlist, a Useful Predictor of Mortality in Liver T...Patel J, Huang CC, Taefi A, and Lalos AT, American College of Gastroenterology annual meeting, 1/1/2016
- Model for End-stage Liver Disease (MELD) as a Predictor of Post-Transplant Survival.Patel J, Huang CC, Taefi A, and Lalos AT, American College of Gastroenterology annual meeting, 1/1/2016
- Join now to see all
Lectures
- "Challenges in relation to liver transplant and liver cancer in patients with Hepatitis C."Washington, DC - 1/1/2017
- "Non-alcoholic fatty liver disease- Emerging therapeutic options"Washington, DC - 1/1/2017
- "Hepatology Board Review"Arlington, VA - 1/1/2017
- Join now to see all
Professional Memberships
- Member
- AASLDMember
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: